FCM-R
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FCM-R, covering 2018-12-06 to 2018-12-06. Get the full timeline:
Most recent: Clinical Trial Update: FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years [Phase 2]